Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mitochondrial thioredoxin reductase is essential for early postischemic myocardial protection.

Horstkotte J, Perisic T, Schneider M, Lange P, Schroeder M, Kiermayer C, Hinkel R, Ziegler T, Mandal PK, David R, Schulz S, Schmitt S, Widder J, Sinowatz F, Becker BF, Bauersachs J, Naebauer M, Franz WM, Jeremias I, Brielmeier M, Zischka H, Conrad M, Kupatt C. Mitochondrial thioredoxin reductase is essential for early postischemic myocardial protection. Circulation. 2011 Dec 20; 124(25):2892-902.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.